Analyst Ratings for Vanda Pharmaceuticals (VNDA)
VNDA Rating Summary
VNDA Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $7.50 (Jefferies)
- Average: $13.70
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.70 (+152.8%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
Avg. $ Target:
$13.70 (+152.8%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Truist Securities » Updated 3/27/2026 |
Les Sulewski | New Coverage | Buy (N/A) |
18.00 (N/A) |
8.20 (5.42) |
-33.9% | Details |
| 11/5/2025 | B.Riley » Updated 8/10/2026 |
Madison El-Saadi | New Coverage | Buy (N/A) |
12.00 (17.00) |
4.47 (5.42) |
21.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
